Lust on Europe's Space Plans

The development of the free-flyer will give us expertise in many areas, including control over our own low-gravity materials processing studies and in the various areas of robotics which will be involved in helping maintain and service parts of the platform. In general, Europe will have more freedom than if it had only the attached module. DEPENDENCE ON PUBLIC MONEY Q: Would you explain the rationale behind putting large sums of money from governments, rather than from the private sector, int

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Q: Would you explain the rationale behind putting large sums of money from governments, rather than from the private sector, into space developments?

Lüst: The first thing to understand is that there is little chance of gaining a quick economic return from space science and technology. To promise otherwise is to misrepresent your aims to the public.

The first justification, I would say, is that public money spent this way increases general scientific understanding in areas such as telecommunications, Earth observation and basic areas of science, where the benefits are for socicty as a whole.

Secondly, investment in projects such as the manned space station are likely to produce a commercial return in areas such as a better understanding of materials and biology processes, but this will be some time in the future.

Thirdly, space projects lead indirectly to technological developments in fields such as electronics and materials, which can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies